ETV5 reduces androgen receptor expression and induces neural stem–like properties during neuroendocrine prostate cancer development
Proceedings of the National Academy of Sciences · 2025
DOI: 10.1073/pnas.2420313122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Jongeun Lee und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences, Pohang University of Science and Technology, Pohang, Gyeongbuk 37673, Republic of Korea. Hauptthemen laut MEDLINE: Transcription Factors, Receptors, Androgen, DNA-Binding Proteins, Prostatic Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Research Foundation of Korea (NRF), Ministry of Education (교육부).
Abstract (Originalsprache)
Neuroendocrine prostate cancer (NEPC), an aggressive subtype induced by hormone therapy, lacks effective treatments. This study explored the role of E26 transformation-specific variant 5 (ETV5) in NEPC development. Analysis of multiple prostate cancer datasets revealed that NEPC is characterized by significantly elevated ETV5 expression compared to other subtypes. ETV5 expression increased progressively under hormone therapy through epigenetic modifications. ETV5 induced neural stem–like features in prostate cancer cells and facilitated their differentiation into NEPC under hormone treatment conditions, both in vitro and in vivo. Our molecular mechanistic study identified PBX3 and TLL1 as target genes of ETV5 that contribute to ETV5 overexpression–induced castration resistance and stemness. Notably, obeticholic acid, identified as an ETV5 inhibitor in this study, exhibited promising efficacy in suppressing NEPC development. This study highlights ETV5 as a key transcription factor that facilitates NEPC development and underscores its potential as a therapeutic target for this aggressive cancer subtype.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Life Sciences, Pohang University of Science and Technology, Pohang, Gyeongbuk 37673, Republic of Korea.
- Department of Biology, College of Natural Sciences, Kyungpook National University, Daegu 41566, Republic of Korea.
- Calici Co., Ltd., Korea, Daejeon 34134, Republic of Korea.
- Department of Bio-Artificial Intelligence Convergence, Chungnam National University, Daejeon 34134, Republic of Korea.
- Department of Food and Biotechnology, Korea University, Sejong 30019, Republic of Korea.
- Institute for Convergence Research and Education in Advanced Technology, Yonsei University, Seoul 03722, Republic of Korea.
ORCID-Profile: Jongeun Lee, Yunjung Hur, Hyung-Seok Choi, Joonyoung Park, Yewon Kim, Kyuha Choi, Young Bin Park, Yoontae Lee
Förderung
- National Research Foundation of Korea (NRF)
- Ministry of Education (교육부)
Zitieren
APA
Lee, J., Park, J., Hur, Y., Um, D., Choi, H. S., Park, J., Kim, Y., Lee, J. S., Choi, K., Kim, E., Park, Y. B., Choi, J. M., Kim, T. K., & Lee, Y. (2025). ETV5 reduces androgen receptor expression and induces neural stem–like properties during neuroendocrine prostate cancer development. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2420313122
Vancouver
Lee J, Park J, Hur Y, Um D, Choi HS, Park J, et al. ETV5 reduces androgen receptor expression and induces neural stem–like properties during neuroendocrine prostate cancer development. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2420313122
BibTeX
@article{Lee2025,
author = {Lee, Jongeun and Park, Jiho and Hur, Yunjung and Um, Dahun and Choi, Hyung-Seok and Park, Joonyoung and Kim, Yewon and Lee, Jeon-Soo and Choi, Kyuha and Kim, Eunjeong and Park, Young Bin and Choi, Jae-Mun and Kim, Tae-Kyung and Lee, Yoontae},
title = {ETV5 reduces androgen receptor expression and induces neural stem–like properties during neuroendocrine prostate cancer development},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
doi = {10.1073/pnas.2420313122}
}
EUVIMED